licensor dependence
Depending on rights licensed from others for key products or content.
Exposure · 6 companies
APMD Apnimed, Inc.
Exposed“Oxnimbi depends on third-party intellectual-property rights, particularly the BWH License, with diligence, milestone, and royalty obligations; breach or loss of licensed rights could impair or prevent commercialization.”
INVA Innoviva, Inc.
Exposed“GSK controls development, regulatory, manufacturing, pricing and commercialization decisions, leaving INVA with limited influence over sales effort, market access, product prioritization or resource allocation.”
- Revenue$411.3MYoY +14.7%
- Net income$271.2Mvs $23.4M year ago
- Revenue$106.1MYoY −1.6%
- Net income−$73.9Mvs $89.9M year ago
NFLX Netflix, Inc.
Exposed“Our ability to provide our members with content they can watch depends on studios, content providers and other rights holders licensing rights, including distribution rights, to such content and certain related elements thereof, such as the public performance of music contained within the content we distribute.”
- Revenue$45.2BYoY +15.9%
- Net income$11.0BYoY +26.1%
- Revenue$12.9BYoY +11.8%
- Net income$3.7BYoY +43.9%
SDGR Schrödinger, Inc.
Exposed“Litigation, third-party infringement claims, ownership disputes, or loss of key Columbia University-licensed technology could require costly licenses, redesign, or cessation of affected work.”
- Revenue$255.9MYoY +23.3%
- Net income−$103.3MYoY +44.8%
- Revenue$64.5MYoY +18.7%
- Net income−$37.7MYoY −15.0%
VOGX Vogenx, Inc.
Exposed“Mizagliflozin depends substantially on an exclusive, royalty-bearing global license from Kissei, excluding Korea, Taiwan, and Japan.”
WWB WINDWARD BIO GROUP AG
Exposed“WWB relies on data, development work, and rights from licensors Kelun and HBM for WIN378 and Qyuns for WIN027.”
No companies have a recent 8-K matching these events.
No companies in the selected roles.